Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05516290 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating Clinical Trial Experiences of Individuals With Congestive Heart Failure

StatusUnknown
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 2, 2024 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Dec 2023); last known: Not Yet Recruiting
  2. Primary completion date: Sep 2024 to Sep 2025 Start date: Sep 2023 to Sep 2024 · Completion date: Sep 2025 to Sep 2026v4 Show 2 more changesShow less
    • Start date: Sep 2023 to Sep 2024
    • Completion date: Sep 2025 to Sep 2026
  3. Primary completion date: Sep 18, 2023 to Sep 2024 Start date: Sep 18, 2022 to Sep 2023 · Completion date: Sep 18, 2024 to Sep 2025v3 Show 2 more changesShow less
    • Start date: Sep 18, 2022 to Sep 2023
    • Completion date: Sep 18, 2024 to Sep 2025
  4. Start date: Aug 18, 2022 to Sep 18, 2022 Primary completion date: Aug 18, 2023 to Sep 18, 2023 · Completion date: Aug 18, 2024 to Sep 18, 2024v2 Show 2 more changesShow less
    • Primary completion date: Aug 18, 2023 to Sep 18, 2023
    • Completion date: Aug 18, 2024 to Sep 18, 2024
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Clinical trial participation has always been substantially skewed toward certain demographic groups. However, there has been little study on whether trial qualities impact participation in either a positive or negative way. The goal of this research is to identify the characteristics that consistently restrict patients' ability to participate in or complete a trial in which they were initially interested. This data will be evaluated via a number of demographic lenses in order to find trends that could benefit future Congestive Heart Failure sufferers.
Trial Details
NCT Number NCT05516290
Lead Sponsor Power Life Sciences Inc.
Conditions Congestive Heart Failure
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov